J Korean Soc Transplant.
2006 Jun;20(1):121-123.
Severe Erythrocytosis after Renal Transplantation: Report of One Case
- Affiliations
-
- 1Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. kmhyj@smc.samsung.co.kr
Abstract
- Erythrocytosis after kidney transplantation is common complications of Renal Transplantation. It afflicts 5~15% of renal transplant recipients and is associated with an increased incidence of thromboembolic events. It is correlated with use of cyclosporine, sex, posttranaplant renal function and type of antihypertensive medications. Invasive therapies for posttransplant erythrocytosis is serial phlebotomy and native nephrectomy. Usually medical therapy with Renin-Angiotensin inhibitor is preferred to invasive therapies. This drug lowers serum level of erythropoietin and then effectively lowers the hematocrit and hemoglobin level. We report the case of a 31-year-old male who had erythrocytosis after renal transplantation. Its hematocrit level is 60% and hemoglobin is 20.2 g/dL. We treated this patient with serial phlebotomy and Enalapril.
